Crossmark

Caffeic acid phenethyl ester derivative exerts remarkable anti-hepatocellular carcinoma effect, non-inferior to sorafenib, in vivo analysis

Published Online: 2024-06-24

Authors

Gong, Lei

Wang, Wenzhen

Yu, Fei

Deng, Zenghua

Luo, Nan

Zhang, Xinjing

Chen, Jianfen

Peng, Jirun
License Information

Text and Data Mining valid from 2024-06-24

Version of Record valid from 2024-06-24
More Information

Article History

Received: 18 April 2024

Accepted: 20 June 2024

First Online: 24 June 2024

Competing interests

: The authors declare no competing interests.

Document is current